Khaled Suleiman Al-Saleem
Chief Executive Officer · In the role since before 26 May 2026 until 26 May 2026Mouwasat Medical Services Co. shares: −11% after leaving.
Mouwasat Medical Services Co. is a company listed on Tadawul in the Health Care Equipment & Svc sector.
Each pin above the line is a change on the board or in management. You can see straight away what happened to the share price afterwards.
For each CEO: the two years before appointment, the time in post, and the two years after departure.
Mouwasat Medical Services Co. shares: −11% after leaving.
Mouwasat Medical Services Co. shares: −17% after leaving.
Mouwasat Medical Services Co. shares: +116% during the role, then −36% after leaving.
Change = from the first to the last value available within each period. Revenue and profit are annual; the price is the daily close, adjusted for splits. What happens during a person's time in a role does not mean they caused it.
Bar length shows length of service. The figures are the change in share price and annual revenue since the member joined; they do not mean the member caused them.
1 other member has no recorded joining date, so we calculate nothing for them.
Each name leads you to another company
Sector Health Care Equipment & Svc · Board independence = independent members out of those classified
| Company | Board independence | Average tenure | Revenue growth · 3 years | Share-price change · 3 years |
|---|---|---|---|---|
| Mouwasat Medical Services Co. (this company) | 4/8 | 4.9 yrs | +38% | −47% |
| AME Company for Medical Supplies | 2/5 | 2.1 yrs | +58% | +63% |
| Saudi Chemical Co. | 6/9 | 1.8 yrs | +86% | +61% |
| Professional Medical Expertise Co. | 1/4 | 3 yrs | +138% | +10% |
| Dr. Sulaiman Al Habib Medical Services Group | 4/9 | 1.9 yrs | +65% | −18% |
| National Medical Care Co. | 5/9 | 3.4 yrs | +74% | −20% |
| Naba Alsaha Medical Services Co. | 0/3 | 3.5 yrs | +56% | −21% |
Disclaimer
The platform shows company data and events to help with monitoring and analysis. The content is informational and is not a recommendation to buy or sell. Company disclosures are the reference for details and the latest developments.
Spotted a problem with the data? Send us a correction